oxycodone has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, J; Li, D; Li, L; Tan, D; Xu, H; Yan, H; Yu, Y | 1 |
| Akizuki, A; Shimoyama, M; Shimoyama, N; Takahashi, H | 1 |
1 review(s) available for oxycodone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
[Palliative medicine for advanced gynecological malignancy].
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Bone Neoplasms; Drug Therapy, Combination; Female; GABA Agonists; Genital Neoplasms, Female; Humans; Ketamine; Morphine; Muscle Neoplasms; Neoplasm Invasiveness; Nerve Block; Oxycodone; Pain, Intractable; Palliative Care; Peritonitis; Receptors, N-Methyl-D-Aspartate | 2004 |
1 other study(ies) available for oxycodone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells.
Topics: Analgesics, Opioid; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caco-2 Cells; Cell Movement; Cell Proliferation; Drug Interactions; ErbB Receptors; Humans; Neoplasm Invasiveness; Neoplasms; Oxidative Stress; Oxycodone; Signal Transduction | 2020 |